AS/Spondyloarthritis
Dr. Jack Cush does a 2-week review of RheumNow Tweets on news and journal citations worth noting, along with some opinions on Telehealth, manpower, monkeypox and the price of drugs.
Although Rheumatology currently ranks 2nd or 3rd in specialty use of telemedicine - the vast majority of rheums have given up on telehealth (<15%) https://t.co/iDNesBkOnN
There are still questions surrounding COVID-19, and some common questions I receive from patients revolve around what to do with their current DMARDs or should they even start treatment during this pandemic. Two studies focused on this question.
Dr. John Cush RheumNow
3 years 3 months ago
450 axSpA pts followed 2868 Pt-yrs, 48% on TNFis. TNFi Rx pts had reduced CV risk (HR 0.30; 0.10–0.85), but no longer signif after adjustment for CRP, ESR (HR 0.37, 0.12–1.12, p = 0.077). Reduced CV risk, may not be specifically due to TNFi use https://t.co/mVHYn3PteL https://t.co/bgKWreBL8z
Dr. John Cush RheumNow
3 years 3 months ago
Watch: The Microbiome in Spondyloarthritis
Can microbes trigger SpA/PsA?
https://t.co/KN7dMFU9qo https://t.co/k3M5QfwqGp
Dr. Jack Cush reviews the top abstracts from EULAR 2022 As chosen by me with the aid of the RheumNow EULAR faculty. “Top” is relative and subjective, but my criteria for inclusion are based on impact, water cooler talk potential, innovation and social media buzz. Speaking of social media…
Dr. John Cush RheumNow
3 years 3 months ago
Watch: Let’s Talk about Sex and Autoimmune Disease
Dr. Eric Dein discusses abstract OP0139 presented at #EULAR2022.
https://t.co/fNcIbykFqL https://t.co/6UaH5DIc51
Differences across genders in many aspects related to rheumatic diseases diagnosis, phenotyping, trajectories definition and prediction of response to treatment have been overlooked. Two abstracts have shed light on relevant gender-based differences in AxSpA assessment or treatment.
Dr. Antoni Chan synovialjoints
3 years 3 months ago
Updates on Axial SpA from #EULAR2022 @RheumNow https://t.co/0dGPUpksxT
Dr. John Cush RheumNow
3 years 3 months ago
Update on Axial SpA at #EULAR2022
This year at EULAR 2022, there were important and interesting topics in Axial Spondyloarthritis (AxSpA).
Dr Antoni Chan shares his picks of abstracts from the conference.
https://t.co/AhUC7ORrZi https://t.co/1olLoNS5Ey
Dr. John Cush RheumNow
3 years 3 months ago
Spondyloarthritis and COVID-19
With the availability of vaccines and new therapeutics, many of our patients are fully vaccinated. We know this can limit their chances of severe COVID all while allowing their rheumatic disease to be treated. #EULAR2022
https://t.co/PmQNKYg1Ao https://t.co/N4DJVYJqrL
This year at EULAR 2022, there were important and interesting topics in Axial Spondyloarthritis (AxSpA). These are my picks of abstracts from the conference.
Poster Hall